Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
Pentagon Taps Gavin Kliger as CDO Amid AI Push
Gavin Kliger will help coordinate the Pentagon’s growing AI initiatives as leaders overhaul acquisition processes to deliver advanced capabilities faster.
3m read -
Army’s FUZE Program Speeds Path to Fielding Emerging Tech
Director Matthew Willis says FUZE is reshaping defense innovation by funding prototypes quickly and scaling successful tech in months instead of years.
4m read -
New Navy Platform Aims to Improve Medical Recordkeeping at Sea
The Operational Medical Care Delivery Platform captures patient care data aboard ships and integrates it with U.S.-based military medical networks.
4m read -
Staying Ahead of AI-Driven Cyber Threats
Robert Roser shares insights on emerging cybercrime trends, supply chain risks and how federal organizations can build stronger security through zero trust.
8m watch
